AOA DX, Inc is a pioneering company in the field of glycolipids, dedicated to transforming women's health through early cancer detection. Their revolutionary tumor marker ganglioside platform is paving the way for life-saving early cancer detection, utilizing data science and AI technology to provide remarkable insights.
Committed to innovation, AOA DX is a team of industry experts and entrepreneurs who are devoted to bringing impactful and cost-effective medical technologies from research and development into the hands of providers and patients. With a mission to raise the bar in women's health, they are actively seeking dedicated teammates to join them on their transformative journey.
Generated from the website